Abstract
The destruction of the biological aortic valve prosthesis is directly proportional to the settings for surgical implantation of the biological valves during primary surgery. Traditionally, the "gold standard" is the surgical method of aortic valve replacement with the implantation of various types of mechanical and biological prostheses. However, the general increase in the number of transcatheter implantations of stent valves in the positions of the aortic valve over the past couple of decades opens new horizons and expands the indications of such procedures in various groups of patients. Against the background of the total number of transcatheter aortic valve replacement (TAVR), reliable data indicate the comparability of TAVR data with the surgical approach and the advantage of TAVR in specific clinical scenarios.
We present a description of a clinical case of elimination of severe aortic insufficiency 10 years after replacing the aortic valve with a biological prosthesis against the background of the destruction of the valves of the valve apparatus using the valve-in-valve TAVR technique
References
- Brown J.M., O'Brien S.M., Wu C., Sikora J.A., Griffith B.P., Gammie J.S. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac. Cardiovasc. Surg. 2009; 137: 82–90. DOI: 10.1016/j.jtcvs.2008.08.015
- Zellner J.L., Kratz J.M., Crumbley A.J., Stroud M.R., Bradley S.M., Sade R.M. Long-term experience with the St. Jude Medical valve prosthesis. Ann. Thorac. Surg. 1999; 68: 1210–8. DOI: 10.1016/s0003-4975(99)00985-6
- Johnston D.R., Soltesz E.G., Vakil N., Rajeswaran J., Roselli E.E., Sabik J.F. et al. Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants. Ann. Thorac. Surg. 2015. 99 4: 1239– 47. DOI: 10.1016/j.athoracsur.2014.10.070
- Writing Committee Members, Otto C.M., NishimuraR.A., Bonow R.O., Carabello B.A., Erwin J.P., Gentile F. et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 2020; 135 (25): 1159– 95. DOI: 10.1016/j.jacc.2020.11.018
- Phan K., Zhao D.F, Wang N., Huo Y.R., Di Eusanio M., Yan T.D. Trans-catheter valve-in-valve implantation versus reoperative conventional aortic valve replacement: a systematic review. J. Thorac. Dis. 2016; 8 (1): E83–E93. DOI: 10.3978/j.issn.2072-1439.2016.01.44
- Takagi H., Mitta S., Ando T. Meta-analysis of valvein-valve trans-catheter versus redo surgical aortic valve replacement. Thorac. Cardiovasc. Surg. 2019; 67 (4): 243–50. DOI: 10.1055/s-0038-1668135
- Walther T., Falk V., Dewey T., Kempfert J., Emrich F., Pfannmüller B. et al. Valve-in-a-Valve concept for transcatheter minimally invasive repeat xenograft implantation. Am. Coll. Cardiol. 2007; 50 (1): 56–60. DOI.org/10.1016/j.jacc.2007.03.030
- Wenaweser P., Buellesfeld L., Gerckens U., Grube E. Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: the first valve in valve procedure using the Corevalve Revalving system. Catheter. Cardiovasc. Interv. 2007; 70 (5): 760–4. DOI.10.1002/ccd.21300
- Azadani A.N., Tseng E.E. Transcatheter valve-in-valve implantation for failing bioprosthetic valves. Future Cardiol. 2010; 6: 811–31. DOI: 10.2217/fca.10.106
- Azadani A.N., Reardon M., Simonato M., Aldea G., Nickenig G., Kornowski R. et al. Effect of transcatheter aortic valve size and position on valvein-valve hemodynamics: An in vitro study. J. Thorac. Cardiovasc. Surg. 2017; 153 (6): 1303–15. DOI: 10.1016/j.jtcvs.2016.12.057
- Majmundar M., Doshi R., Kumar A., Johnston D., Brockett J., Kanaa N.A. et al. Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis. EuroIntervention. 2021; EIJ-D-21-00472. DOI: 10.4244/EIJ-D-21-00472
- Otto C.M., Nishimura R.A., Bonow R.O., Carabello B.A., Erwin J.P., Gentile F. et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021; 143: e35-e71. DOI: 10.1161/cir.0000000000000932
- Sa M., Van den Eynde J., Simonato M., CavalcantiL.R.P., Doulamis I.P., Weixler V. et al. Valve-in-valve transcatheter aortic valve replacement versus redo surgical aortic valve replacement: An Updated metaanalysis. JACC Cardiovasc. Interv. 2021; 14: 211–20. DOI: 10.1016/j.jcin.2020.10.020
- Mahmoud A.N., Gad M.M., Elgendy I.Y., Mahmoud A.A., Taha Y. Elgendy A.Y. et al. Systematic review and meta-analysis of valve-in-valve transcatheter aortic valve replacement in patients with failed bioprosthetic aortic valves. EuroIntervention. 2020; 16 (7): 539–48. DOI: 10.4244/EIJ-D-19-00928
- Petrosyan K.V., Dadabaev G.M., Titov D.A., Sorkomov M.N., Salokhiddinov M.A., Losev V.V. et al. Successful aortic valve replacement using the valve-invalve technique after a previous aortic valve replacement with the Arbor Trilogy sutureless two-piece biological prosthesis. Russian Journal of Endovascular Surgery. 2021; 8 (2): 215–21 (in Russ.). DOI: 10.24183/2409- 080-2021-8-2-215-221
About the authors
- Karen V. Petrosyan, Dr. Med. Sci., Endovascular Surgeon; ORCID
- Gulumzhan M. Dadabaev, Cand. Med. Sci., Junior, Endovascular Surgeon; ORCID
- Vladimir V. Losev, Cand. Med. Sci.; ORCID
- Meri V. Petrosyan, Cand. Med. Sci., Cardiologist; ORCID
